Antila, S <br/><br/>
Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril.  [electronic resource] 

 -  European journal of clinical pharmacology  1996 
 - 451-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0031-6970 
<br/><br/><label>Standard No.: </label>10.1007/BF00195930  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacokinetics<br/>Blood Pressure--drug effects<br/>Captopril--pharmacokinetics<br/>Cardiac Output--drug effects<br/>Cardiotonic Agents--pharmacokinetics<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Drug Interactions<br/>Echocardiography--drug effects<br/>Electrocardiography, Ambulatory--drug effects<br/>Half-Life<br/>Heart Failure--drug therapy<br/>Heart Rate--drug effects<br/>Hemodynamics--drug effects<br/>Humans<br/>Hydrazones--pharmacokinetics<br/>Injections, Intravenous<br/>Male<br/>Middle Aged<br/>Myocardial Contraction--drug effects<br/>Pyridazines--pharmacokinetics<br/>Simendan